FindTrial
Sign In

Effect of uNK cell percentage in mid luteal phase on pregnancy outcome of patients with repeated implantation failure

Effect of uNK cell percentage in mid luteal phase on pregnancy outcome of patients with repeated implantation failure

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300067297
Enrollment
Unknown
Registered
2023-01-03
Start date
2022-10-16
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent implantation failure

Interventions

case series:Null

Sponsors

Shenzhen Zhongshan Urology Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
23 Years to 47 Years

Inclusion criteria

Inclusion criteria: 1. Patients with repeated implantation failure; 2. Newly diagnosed patients in the center; 3. The patient's visit time is from September 1, 2017 to January 31, 2021.

Exclusion criteria

Exclusion criteria: 1. Patients who have not been tested for uNK; 2. Patients who have not undergone embryo transfer within six months after endometrial immune cell examination; 3. Patients with natural pregnancy.

Design outcomes

Primary

MeasureTime frame
uNK cell percentage in mid luteal phase;Clinical pregnancy rate;—

Secondary

MeasureTime frame
HCG positive rate;Ongoing pregnancy rate;Live birth rate;—

Countries

China

Contacts

Public ContactHuang Chunyu/Zeng Yong

Shenzhen Zhongshan Urology Hospital

zengyong1966@gmail.com+86 18128879114/+86 13008871163

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026